January 26, 2024Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
January 9, 2024Nanoform Management Presentation - SEB Nordic Seminar Copenhagen
Questions from investors, analysts and journalists
